Once a Patient’s in Custody, ICE Can Be at Hospital Bedsides — But Detainees Have Rights
In July, federal immigration agents took Milagro Solis-Portillo to Glendale Memorial Hospital just outside Los…
Once a Patient’s in Custody, ICE Can Be at Hospital Bedsides — But Detainees Have Rights
In July, federal immigration agents took Milagro Solis-Portillo to Glendale Memorial Hospital just outside Los Angeles after she suffered a medical emergency while being detained. They didn’t leave. For two weeks, Immigration and Customs Enforcement contractors sat guard in the hospital lobby 24 hours a day, working in shifts to monitor her movements, her attorney…
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the cheaper medicines to get on the market, industry officials say. These officials were thrilled Oct. 29 when FDA Commissioner Marty Makary announced the…
Support your neighborhood scientist
By KIM BELLARD These are, it must be said, grim times for American science. Between the Trump budget cuts, the Trump attacks on leading research universities, and the normalization of misinformation/ disinformation, scientists are losing their jobs, fleeing to other countries, or just trying to keep their heads down in hopes of being able to…
Why Shared Savings Still Isn’t a Viable Business Model for Hospitals
Shared savings programs are appealing in theory, but the incentives are too weak and unpredictable to support a scalable business model for hospitals, said Patrick Runnels, chief medical officer of University Hospitals. The post Why Shared Savings Still Isn’t a Viable Business Model for Hospitals appeared first on MedCity News.
Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs
Iambic’s latest financing follows the presentation of data for its breast cancer drug during the recent European Society of Medical Oncology conference. Our financing roundup includes capital raised by startups developing novel therapies immunology, metabolic disorders, genetic diseases, and more. The post Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs appeared first…
Late-in-Life Autism Diagnosis: Why Adults Still Face So Many Barriers and How We Can Do Better
Awareness of autism has grown, but we need to move beyond this into understanding and acceptance. Real progress depends on how we translate understanding into action — training more professionals, funding adult services, and redesigning workplaces and communities so autistic individuals can flourish throughout their lifespan. The post Late-in-Life Autism Diagnosis: Why Adults Still Face…
Food Is Medicine Needs Data To Thrive
To make sure that Food is Medicine interventions are delivered the right way, we must be deliberate and proactive in how we collect and share data. The post Food Is Medicine Needs Data To Thrive appeared first on MedCity News.
Journalists Untangle Issues of Health Care Costs and Food Benefits
KFF Health News Southern California correspondent Claudia Boyd-Barrett discussed rising health care premiums on KPFA’s “Up Front” on Nov. 13. Click here to hear Boyd-Barrett on “Up Front” (starts at 08:19). Read Boyd-Barrett’s “Health Care Costs Jump to the Fore as Candidates Jockey To Be California Governor.” KFF Health News chief Washington correspondent Julie Rovner…
Merck Makes Big Antiviral Move With $9B Deal to Land Cidara’s Late-Stage Drug for Flu Prevention
Merck’s Cidara Therapeutics acquisition brings a lead program with potential to become a first-in-class drug for preventing influenza infection. A Phase 3 study is already underway, timed to coincide with the start of the flu season in the Northern Hemisphere. The post Merck Makes Big Antiviral Move With $9B Deal to Land Cidara’s Late-Stage Drug…
Will Trump’s Team Slow Supersized Health Mergers?
Rising health care costs and the impending expiration of expanded Obamacare subsidies fueled the record-setting government shutdown that ended this week. But there’s another driver of escalating costs and prices playing out in a far broader, more impactful way: the rapid consolidation of insurers, hospital systems, doctors’ groups, and pharmacies into behemoths, effectively giving them…
